| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | CENPE PACSIN1 MYO9B ANXA2 ANXA2P2 MYO19 SPTB TRPC6 PACSIN3 EPB41L5 JMY ADCY8 CRK CRMP1 PPP2R2A BRCA2 SYNE2 CEP70 SNTG2 PPP1R9B TTLL1 MTCL1 CTTN PLS1 | 9.08e-06 | 1099 | 162 | 24 | GO:0008092 |
| GeneOntologyMolecularFunction | bone sialoprotein binding | 6.54e-05 | 2 | 162 | 2 | GO:0044730 | |
| GeneOntologyBiologicalProcess | articular cartilage development | 2.49e-05 | 8 | 160 | 3 | GO:0061975 | |
| GeneOntologyBiologicalProcess | protein localization to plasma membrane | TSPAN15 PACSIN1 ANXA2 ANXA2P2 LAMA5 DENND4C LRP1 PPP1R9B SESN2 FYB1 PLS1 | 4.71e-05 | 324 | 160 | 11 | GO:0072659 |
| GeneOntologyBiologicalProcess | positive regulation of low-density lipoprotein particle receptor binding | 5.98e-05 | 2 | 160 | 2 | GO:1905597 | |
| GeneOntologyBiologicalProcess | cAMP transport | 5.98e-05 | 2 | 160 | 2 | GO:0070730 | |
| GeneOntologyCellularComponent | actin cytoskeleton | CALB1 MYO9B ANXA2 ANXA2P2 MYO19 SPTB DAPK1 ADCY8 CRK CRMP1 PJVK PPP1R9B PEAK1 CTTN FYB1 PLS1 | 1.01e-05 | 576 | 161 | 16 | GO:0015629 |
| GeneOntologyCellularComponent | cortical cytoskeleton | 6.42e-05 | 129 | 161 | 7 | GO:0030863 | |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 8.34e-05 | 93 | 161 | 6 | GO:0030864 | |
| GeneOntologyCellularComponent | cell cortex | CALB1 MYO9B ANXA2 ANXA2P2 SPTB PJVK PDE4DIP SEPTIN1 PPP1R9B CTTN PLS1 | 1.47e-04 | 371 | 161 | 11 | GO:0005938 |
| GeneOntologyCellularComponent | AnxA2-p11 complex | 1.76e-04 | 3 | 161 | 2 | GO:1990665 | |
| GeneOntologyCellularComponent | PCSK9-AnxA2 complex | 1.76e-04 | 3 | 161 | 2 | GO:1990667 | |
| GeneOntologyCellularComponent | membrane protein complex | SYNRG TRPC7 CLTCL1 ANXA2 ANXA2P2 TRPC6 CDH19 DENND4C MAP3K5 MEP1B CD247 IGF1R TOMM40L DNAJC11 SYNE2 CNTNAP2 LRP1 OLFM1 CD79A SNTG2 CACNA1G GNAI2 GNAZ CTTN CDH3 | 2.02e-04 | 1498 | 161 | 25 | GO:0098796 |
| GeneOntologyCellularComponent | midbody | 3.33e-04 | 222 | 161 | 8 | GO:0030496 | |
| GeneOntologyCellularComponent | platelet dense granule | 5.39e-04 | 21 | 161 | 3 | GO:0042827 | |
| GeneOntologyCellularComponent | glutamatergic synapse | PRUNE2 CALB1 PACSIN1 SPTB LAMA5 DAPK1 ADCY8 NCS1 PPP2R2A NTNG2 IGF1R CNTNAP2 LRP1 OLFM1 PRKAR2A CTTN | 5.87e-04 | 817 | 161 | 16 | GO:0098978 |
| GeneOntologyCellularComponent | trans-Golgi network transport vesicle membrane | 6.20e-04 | 22 | 161 | 3 | GO:0012510 | |
| GeneOntologyCellularComponent | ruffle | 1.11e-03 | 206 | 161 | 7 | GO:0001726 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | ANXA2 ANXA2P2 CDH19 CD247 IGF1R CNTNAP2 LRP1 OLFM1 CD79A SNTG2 CACNA1G GNAI2 GNAZ CTTN CDH3 | 1.12e-03 | 785 | 161 | 15 | GO:0098797 |
| GeneOntologyCellularComponent | myelin sheath adaxonal region | 1.21e-03 | 7 | 161 | 2 | GO:0035749 | |
| GeneOntologyCellularComponent | anchoring junction | DCHS2 CDHR2 ANXA2 TRPC6 EPB41L5 CDH19 UBA1 SYNE2 CNTNAP2 LRP1 TJP2 PRKAR2A PPP1R9B PEAK1 CTTN FYB1 CDH3 | 1.44e-03 | 976 | 161 | 17 | GO:0070161 |
| GeneOntologyCellularComponent | axon | DHX36 CALB1 MYCBP2 PACSIN1 ADCY8 NCS1 CRMP1 NTNG2 IGF1R CNTN5 UHMK1 CNTNAP2 LRP1 OLFM1 PPP1R9B CTTN | 1.46e-03 | 891 | 161 | 16 | GO:0030424 |
| GeneOntologyCellularComponent | extracellular matrix | FRAS1 MXRA5 EPYC ANXA2 ANXA2P2 LAMA5 OGN ITIH3 OPTC P3H2 PODN CLEC3B LRRC17 | 1.74e-03 | 656 | 161 | 13 | GO:0031012 |
| GeneOntologyCellularComponent | cell leading edge | PACSIN1 MYO9B ANXA2 ANXA2P2 EPB41L5 JMY SYNE2 CNTNAP2 PPP1R9B CTTN PLCE1 | 1.75e-03 | 500 | 161 | 11 | GO:0031252 |
| GeneOntologyCellularComponent | external encapsulating structure | FRAS1 MXRA5 EPYC ANXA2 ANXA2P2 LAMA5 OGN ITIH3 OPTC P3H2 PODN CLEC3B LRRC17 | 1.79e-03 | 658 | 161 | 13 | GO:0030312 |
| GeneOntologyCellularComponent | nuclear speck | 1.92e-03 | 431 | 161 | 10 | GO:0016607 | |
| GeneOntologyCellularComponent | protein kinase complex | 2.07e-03 | 170 | 161 | 6 | GO:1902911 | |
| Pubmed | ABCC4 NAALAD2 CLTCL1 MYCBP2 CENPE MYO9B ZC3H13 FAT3 SPTB ABCC5 SRP72 DAPK1 ARFIP1 JMY DENND4C CACTIN UBE2R2 IGF1R UBE2S HERC2 CDH3 | 2.82e-07 | 1215 | 163 | 21 | 15146197 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PRUNE2 HBS1L ANP32B ANXA2 SRP72 QRICH1 API5 ARFIP1 NCS1 CRMP1 UBE2R2 PPP2R2A UBA1 ANP32A TJP2 PRKAR2A GNAI2 LTV1 LRBA CTTN NMT1 G6PD PLS1 | 3.50e-07 | 1455 | 163 | 23 | 22863883 |
| Pubmed | Secretion of Annexin II via activation of insulin receptor and insulin-like growth factor receptor. | 4.03e-07 | 4 | 163 | 3 | 12431980 | |
| Pubmed | MYT1L DCHS2 MYCBP2 FOLH1 SPTB APBA2 ABCC5 QRICH1 PLEKHB1 DCAF5 TRIM52 CRMP1 PDE4DIP YLPM1 CEP70 LRP1 OLFM1 LRBA HERC2 CTTN CABIN1 | 6.98e-07 | 1285 | 163 | 21 | 35914814 | |
| Pubmed | MYCBP2 CENPE NHSL2 ZNF618 DAPK1 CRMP1 MAP3K5 UBA1 SYNE2 PDE4DIP YLPM1 LRP1 PRKAR2A PPP1R9B MTCL1 HERC2 CTTN CABIN1 | 7.04e-07 | 963 | 163 | 18 | 28671696 | |
| Pubmed | Semaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancer. | 1.00e-06 | 5 | 163 | 3 | 26243191 | |
| Pubmed | 1.28e-06 | 225 | 163 | 9 | 12168954 | ||
| Pubmed | HBS1L ANXA2 EPB41L5 ABCC5 SRP72 TAB2 ARFIP1 DENND4C CRK UBA1 MB21D2 LTV1 PEAK1 LRBA CTTN | 1.37e-06 | 708 | 163 | 15 | 39231216 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | TSPAN15 HBS1L ABCC4 NHSL2 MCFD2 PACSIN3 EPB41L5 ABCC5 DAPK1 DENND4C ANP32A TYW1 PEAK1 LRBA HERC2 | 1.66e-06 | 719 | 163 | 15 | 35337019 |
| Pubmed | Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities. | 5.56e-06 | 8 | 163 | 3 | 15719014 | |
| Pubmed | SYNRG ABAT MYCBP2 ANXA2 ANXA2P2 APBA2 NCS1 UBA1 DNAJC11 PDE4DIP ANP32A CNTNAP2 TJP2 OLFM1 PRKAR2A PPP1R9B PEAK1 CTTN | 7.31e-06 | 1139 | 163 | 18 | 36417873 | |
| Pubmed | 8.74e-06 | 285 | 163 | 9 | 34369648 | ||
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | MYO9B SPTB GBE1 SDAD1 TGM5 KLHL22 UBA1 YLPM1 LTV1 GNAZ G6PD PLS1 RSPH10B LRRC17 | 9.99e-06 | 732 | 163 | 14 | 34732716 |
| Pubmed | 1.10e-05 | 371 | 163 | 10 | 25241761 | ||
| Pubmed | SYNRG HBS1L MYCBP2 ANXA2 RBM10 CRK UBA1 YLPM1 TJP2 PEAK1 LRBA CTTN | 1.19e-05 | 549 | 163 | 12 | 38280479 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | CLTCL1 CDHR2 FOLH1 ANXA2 ANXA2P2 VPS4B PACSIN3 LAMA5 GBE1 OGN ITIH3 UBA1 KL PRKAR2A C1R CLEC3B G6PD | 1.24e-05 | 1070 | 163 | 17 | 23533145 |
| Pubmed | MEAF6 AKT3 CLTCL1 ANP32B MYO19 PACSIN3 GBE1 SRP72 AK6 JMY SDAD1 PPP2R2A GID4 SYNE2 ANP32A TJP2 UNC93B1 CTTN CABIN1 G6PD | 1.46e-05 | 1440 | 163 | 20 | 30833792 | |
| Pubmed | Developmental expression of heterotrimeric G-proteins in the murine cerebellar cortex. | 1.62e-05 | 11 | 163 | 3 | 11685543 | |
| Pubmed | 1.62e-05 | 11 | 163 | 3 | 12796502 | ||
| Pubmed | MEAF6 AKT3 MRS2 APBA2 CACTIN NTNG2 DNAJC11 ANP32A OLFM1 CD79A UNC93B1 NMT1 | 1.67e-05 | 568 | 163 | 12 | 9110174 | |
| Pubmed | Klotho suppresses tumor progression via inhibiting IGF-1R signaling in T‑cell lymphoma. | 2.18e-05 | 2 | 163 | 2 | 28656297 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 12556535 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 29958938 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 15263018 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 19536308 | ||
| Pubmed | Annexin A2 modulates radiation-sensitive transcriptional programming and cell fate. | 2.18e-05 | 2 | 163 | 2 | 23148505 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 38290972 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 3013423 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 35064931 | ||
| Pubmed | Complex Roles of Annexin A2 in Host Blood-Brain Barrier Invasion by Cryptococcus neoformans. | 2.18e-05 | 2 | 163 | 2 | 28130864 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 28465009 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 17549680 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 39384746 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 20826156 | ||
| Pubmed | Prohibitin/annexin 2 interaction regulates fatty acid transport in adipose tissue. | 2.18e-05 | 2 | 163 | 2 | 27468426 | |
| Pubmed | Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis. | 2.18e-05 | 2 | 163 | 2 | 19841537 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 1408147 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 27389701 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 17360942 | ||
| Pubmed | Annexin A2 regulates phagocytosis of photoreceptor outer segments in the mouse retina. | 2.18e-05 | 2 | 163 | 2 | 19587120 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 19022301 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 38253182 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 23529130 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 23061379 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 25521631 | ||
| Pubmed | Annexin A2 is a novel cellular redox regulatory protein involved in tumorigenesis. | 2.18e-05 | 2 | 163 | 2 | 22185818 | |
| Pubmed | PLC-mediated PI(4,5)P2 hydrolysis regulates activation and inactivation of TRPC6/7 channels. | 2.18e-05 | 2 | 163 | 2 | 24470487 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 12695538 | ||
| Pubmed | A competitive hexapeptide inhibitor of annexin A2 prevents hypoxia-induced angiogenic events. | 2.18e-05 | 2 | 163 | 2 | 21486955 | |
| Pubmed | An evaluation of OPTC and EPYC as candidate genes for high myopia. | 2.18e-05 | 2 | 163 | 2 | 19844586 | |
| Pubmed | Lipid raft endocytosis and exosomal transport facilitate extracellular trafficking of annexin A2. | 2.18e-05 | 2 | 163 | 2 | 21737841 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 19580511 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 19903828 | ||
| Pubmed | Klotho Ameliorates Podocyte Injury through Targeting TRPC6 Channel in Diabetic Nephropathy. | 2.18e-05 | 2 | 163 | 2 | 35480629 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 11120746 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 31063704 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 36739096 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 22517898 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 30462534 | ||
| Pubmed | Inhibition of the membrane repair protein annexin-A2 prevents tumor invasion and metastasis. | 2.18e-05 | 2 | 163 | 2 | 38092984 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 21572519 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 29729191 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 21788340 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 27371724 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 31399517 | ||
| Pubmed | Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart. | 2.18e-05 | 2 | 163 | 2 | 23212367 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 30996088 | ||
| Pubmed | Species specific differences in use of ANP32 proteins by influenza A virus. | 2.18e-05 | 2 | 163 | 2 | 31159925 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 31817350 | ||
| Pubmed | Versatile membrane deformation potential of activated pacsin. | 2.18e-05 | 2 | 163 | 2 | 23236520 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 37832154 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 30902828 | ||
| Pubmed | Cell surface translocation of annexin A2 facilitates glutamate-induced extracellular proteolysis. | 2.18e-05 | 2 | 163 | 2 | 24742684 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 21738216 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 32687500 | ||
| Pubmed | Characterization of the MRP4- and MRP5-mediated transport of cyclic nucleotides from intact cells. | 2.18e-05 | 2 | 163 | 2 | 12637526 | |
| Pubmed | Annexin A2 binds to endosomes following organelle destabilization by particulate wear debris. | 2.18e-05 | 2 | 163 | 2 | 22453828 | |
| Pubmed | Agents that bind annexin A2 suppress ocular neovascularization. | 2.18e-05 | 2 | 163 | 2 | 20607799 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 19678840 | ||
| Pubmed | G-protein alpha-subunit expression, myristoylation, and membrane association in COS cells. | 2.18e-05 | 2 | 163 | 2 | 2153964 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 31253864 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 12204797 | ||
| Pubmed | GCPII and its close homolog GCPIII: from a neuropeptidase to a cancer marker and beyond. | 2.18e-05 | 2 | 163 | 2 | 30844704 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 19628708 | ||
| Pubmed | Annexin A2 binds to the localization signal in the 3' untranslated region of c-myc mRNA. | 2.18e-05 | 2 | 163 | 2 | 15654879 | |
| Pubmed | Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis. | 2.18e-05 | 2 | 163 | 2 | 20847146 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | HBS1L MXRA5 CALB1 CDHR2 ANXA2 VPS4B PACSIN3 LAMA5 GBE1 CRK UBA1 KL PRKAR2A GNAI2 G6PD PLS1 | 2.52e-05 | 1016 | 163 | 16 | 19056867 |
| Pubmed | 3.43e-05 | 339 | 163 | 9 | 37232246 | ||
| Pubmed | 3.72e-05 | 131 | 163 | 6 | 28634551 | ||
| Pubmed | 4.06e-05 | 133 | 163 | 6 | 15144186 | ||
| Pubmed | 5.41e-05 | 16 | 163 | 3 | 11431473 | ||
| Pubmed | 5.41e-05 | 16 | 163 | 3 | 22115758 | ||
| Pubmed | Phospho-proteomic analyses of B-Raf protein complexes reveal new regulatory principles. | 6.42e-05 | 89 | 163 | 5 | 27034005 | |
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 35098646 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 35413401 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 16181796 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 16156793 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 11316748 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 12906859 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 28694388 | ||
| Cytoband | 4q31.3 | 1.84e-04 | 31 | 163 | 3 | 4q31.3 | |
| Cytoband | 4q21.1 | 3.12e-04 | 37 | 163 | 3 | 4q21.1 | |
| GeneFamily | Small leucine rich repeat proteoglycans | 3.81e-05 | 12 | 103 | 3 | 573 | |
| GeneFamily | Cadherin related | 1.15e-04 | 17 | 103 | 3 | 24 | |
| GeneFamily | ANP32 acidic nuclear phosphoproteins | 3.18e-04 | 5 | 103 | 2 | 27 | |
| GeneFamily | PDZ domain containing | 1.78e-03 | 152 | 103 | 5 | 1220 | |
| GeneFamily | ATP binding cassette subfamily C | 2.41e-03 | 13 | 103 | 2 | 807 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#3 | TMEM30B FRAS1 PACSIN3 LAMA5 MAP3K5 SEMA3D TJP2 PODN LRBA CDH3 PLS1 | 1.17e-05 | 283 | 162 | 11 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K3 |
| CoexpressionAtlas | kidney_e15.5_Podocyte_MafB_top-relative-expression-ranked_500 | FRAS1 CALB1 FAT3 EPB41L5 OGN MEP1B SEMA3D SAMD9L P3H2 PJVK RASSF9 PLS1 LRRC17 | 1.74e-05 | 412 | 162 | 13 | gudmap_kidney_e15.5_Podocyte_MafB_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | SOX5 AKT3 CENPE ANXA2 FAT3 EPB41L5 GBE1 BCHE CRMP1 KNOP1 NTNG2 CD247 AATK BRCA2 SYNE2 CNTNAP2 TJP2 PRKAR2A TTLL1 LRBA NMT1 | 2.06e-05 | 986 | 162 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | ABAT TRPC7 CALB1 ZNF618 FAT3 TRPC6 DAPK1 BCHE DENND4C SEMA3D P3H2 CEP70 LRP1 OLFM1 CACNA1G PEAK1 CDH3 LRRC17 | 3.94e-05 | 797 | 162 | 18 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#1 | 4.96e-05 | 125 | 162 | 7 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | TMEM30B FRAS1 PACSIN3 EPB41L5 LAMA5 PRND MAP3K5 SEMA3D DNAJC11 CNTNAP2 TJP2 UBE2S PODN CACNA1G PEAK1 LRBA FYB1 CDH3 PLS1 LRRC17 | 5.39e-05 | 973 | 162 | 20 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | SOX5 CENPE ANP32B FAT3 EPB41L5 PRND SEMA3D BRCA2 DENND4B SYNE2 UHMK1 ANP32A CNTNAP2 CEP70 PRKAR2A PEAK1 LRBA NMT1 FYB1 LRRC17 | 6.21e-05 | 983 | 162 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | TSPAN15 CENPE ZNF618 FAT3 TRPC6 NCS1 SEMA3D BRCA2 P3H2 SYNE2 LRP1 CACNA1G CTTN CDH3 G6PD LRRC17 PLCE1 | 8.35e-05 | 768 | 162 | 17 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#5 | 1.39e-04 | 65 | 162 | 5 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_1000 | PRUNE2 TMEM30B AKT3 ABCC4 MYOM1 CDH19 OGN PLEKHB1 JMY SAMD9L PLEKHA3 UHMK1 CNTNAP2 C1R SNTG2 PLCE1 | 1.62e-04 | 734 | 162 | 16 | gudmap_developingLowerUrinaryTract_adult_bladder_1000 |
| CoexpressionAtlas | kidney_e15.5_Podocyte_MafB_top-relative-expression-ranked_1000 | TMEM30B FRAS1 CALB1 FAT3 EPB41L5 GBE1 OGN MEP1B SEMA3D SAMD9L P3H2 PJVK CACNA1G LRBA RASSF9 PLS1 LRRC17 | 1.68e-04 | 814 | 162 | 17 | gudmap_kidney_e15.5_Podocyte_MafB_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | PACSIN3 EPB41L5 LAMA5 PRND CRMP1 MAP3K5 SEMA3D AATK DNAJC11 CNTNAP2 UBE2S PODN CACNA1G MTCL1 PEAK1 FYB1 CDH3 PLS1 LRRC17 | 1.70e-04 | 976 | 162 | 19 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.74e-04 | 259 | 162 | 9 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | CENPE NHSL2 ANP32B PACSIN3 PRND MAP3K5 SEMA3D AATK BRCA2 DNAJC11 YLPM1 CEP70 PODN CACNA1G PEAK1 LRBA FYB1 CDH3 LRRC17 | 1.74e-04 | 978 | 162 | 19 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.06e-04 | 265 | 162 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_top-relative-expression-ranked_500 | TMEM30B MYCBP2 EPB41L5 LAMA5 F5 MAP3K5 MEP1B SAMD9L UHMK1 CNTNAP2 LRBA | 2.29e-04 | 394 | 162 | 11 | gudmap_developingLowerUrinaryTract_e15.5_urothelium_500 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500 | NAALAD2 MYOM1 EPYC ZC3H13 FAT3 PRND OGN ADCY8 SYNE2 C1R LRRC17 | 2.34e-04 | 395 | 162 | 11 | gudmap_developingGonad_P2_epididymis_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | 2.86e-04 | 277 | 162 | 9 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K3 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.00e-08 | 186 | 163 | 9 | 8915436d09775f2828a7678af203b1082b36e21c | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.61e-08 | 190 | 163 | 9 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-07 | 166 | 163 | 8 | 43f84d3cd58e93ce00c241656c4cba27604b4932 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-07 | 179 | 163 | 8 | 69a1b3b05c921de6343ffe6ad998aa2b804312a7 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-07 | 179 | 163 | 8 | 479116ac65488c60104a053530830763ec1f95b2 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-07 | 179 | 163 | 8 | 1dfc0cb8b369aef35c59f3d4c52603dc9f3728c1 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.44e-07 | 180 | 163 | 8 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-07 | 184 | 163 | 8 | 3bffadb0cb2e0d825bdb6cfc5d23f5436cbc3efd | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.06e-07 | 184 | 163 | 8 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.98e-07 | 189 | 163 | 8 | 473b01c9162b12b90a617c600238436177a0d18d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.84e-07 | 193 | 163 | 8 | adc9fc94f9ec686a417d08c0b8b7b7ab687afec0 | |
| ToppCell | HSPCs-Mk_prog.|HSPCs / Lineage and Cell class | 6.07e-07 | 194 | 163 | 8 | 5c05d508f5c29e6efe87506bf59e3b0fe5922f65 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.81e-07 | 197 | 163 | 8 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | distal-1-mesenchymal-Mesothelial|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.35e-07 | 199 | 163 | 8 | 8dd5b411d2f1626830b77a1616cc3fb67dc59338 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Adventitial_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.35e-07 | 199 | 163 | 8 | 8de6d7b2067b22cb9b5f01aa56a3803aebc4406d | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.15e-06 | 170 | 163 | 7 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-06 | 174 | 163 | 7 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | Posterior_cortex-Macroglia|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.82e-06 | 175 | 163 | 7 | 8bc7a3856d04692989b2a1675ea6d9392261d55a | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-06 | 176 | 163 | 7 | feafc757e7aa4f17128ff34886beb2fd3461c9ea | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.60e-06 | 180 | 163 | 7 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-mesothelial_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.77e-06 | 181 | 163 | 7 | 65eaa9bc1022bcf0c5f0f92c07a2cbbf11f9b59c | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 4.77e-06 | 181 | 163 | 7 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(PRG4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.77e-06 | 181 | 163 | 7 | eaac7d58117eddfff06b25521efc431c1351d592 | |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class | 4.94e-06 | 182 | 163 | 7 | 354dcdb01360597f68c4fe157a682aee1c0b8bb1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.12e-06 | 183 | 163 | 7 | 7c4b775f351794a3de06bd503eecbc8ae8577c44 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.12e-06 | 183 | 163 | 7 | 612d93df03252d4d2ccdce5a9bc162cfd9172a1a | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-06 | 185 | 163 | 7 | 33cc0e9d8b54cb7408b51235f2a70e044ebae04d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.50e-06 | 185 | 163 | 7 | 847257d232b9993cad50c814fd4ffeef52385295 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 5.50e-06 | 185 | 163 | 7 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | Control-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 5.50e-06 | 185 | 163 | 7 | 0af540323c0113203ba6c1a4cb32d2fb9cf79d39 | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-06 | 185 | 163 | 7 | 9954fc85b183c1cc45c3c24e3dadc7984ee6f649 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.33e-06 | 189 | 163 | 7 | c392491aabe8a3e90974ab2ea123bbbe5200439d | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Nr2f2_Necab1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.47e-06 | 124 | 163 | 6 | 298ff8bd8f0459f44ce8a8aea889c6f1cf84ac5f | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.55e-06 | 190 | 163 | 7 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-06 | 190 | 163 | 7 | 1803b1e7c36285f9eaabc3c6e9a9752c5908db3d | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 6.55e-06 | 190 | 163 | 7 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.78e-06 | 191 | 163 | 7 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.78e-06 | 191 | 163 | 7 | 98b907f8fa024cf32e462323b782c5a371327bbd | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.02e-06 | 192 | 163 | 7 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.02e-06 | 192 | 163 | 7 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | COVID-19-kidney-CNT|kidney / Disease (COVID-19 only), tissue and cell type | 7.02e-06 | 192 | 163 | 7 | d32ae226d95b4b6adb99d14b602be09b661d4cd9 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.02e-06 | 192 | 163 | 7 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.02e-06 | 192 | 163 | 7 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.26e-06 | 193 | 163 | 7 | cd45118ced91b10baed3b1068d4673ec99824b86 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.76e-06 | 195 | 163 | 7 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.03e-06 | 196 | 163 | 7 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | 15-Trachea-Mesenchymal|Trachea / Age, Tissue, Lineage and Cell class | 8.03e-06 | 196 | 163 | 7 | 7e178c76285e61c721c38d7a995ebf89dc428f9f | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-MK-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.03e-06 | 196 | 163 | 7 | 66ba31b74953726e9c314f6d8fe3f75d3762e23a | |
| ToppCell | Bronchial-NucSeq-Stromal-Mesofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.03e-06 | 196 | 163 | 7 | 96e5c6d155273e82ebafa180df8bb589c3e3e54e | |
| ToppCell | Bronchial-NucSeq-Stromal-Mesofibroblastic-Mesothelia|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.03e-06 | 196 | 163 | 7 | ce13af36fc2932e8125013041742593ff3d07e86 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class | 8.03e-06 | 196 | 163 | 7 | 54aefcebf13704f51de84379e2e22ec0734b9461 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.30e-06 | 197 | 163 | 7 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.30e-06 | 197 | 163 | 7 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.30e-06 | 197 | 163 | 7 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.57e-06 | 198 | 163 | 7 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.86e-06 | 199 | 163 | 7 | af664e0d41a889a75dbf6cf0d50acd26f5ab3a3a | |
| ToppCell | 356C-Fibroblasts-Fibroblast-F|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.86e-06 | 199 | 163 | 7 | 59fe5f3c6338e019a149ab135acf9cc5657298bf | |
| ToppCell | 356C-Fibroblasts-Fibroblast-F-|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.86e-06 | 199 | 163 | 7 | 136f24597ddca5cf2175120975c94782a3232ec6 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class | 8.86e-06 | 199 | 163 | 7 | f307d4887b28cf60a591439e278fd668409cb104 | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 9.15e-06 | 200 | 163 | 7 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.15e-06 | 200 | 163 | 7 | 93c1db92e0e456101f7895867fc8a1fe45298347 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.15e-06 | 200 | 163 | 7 | 159377d904394d91e09913131e9a93e08189955a | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.15e-06 | 200 | 163 | 7 | 46d0ae385e67030bfaf7062bb6b43da5db05b33a | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 9.15e-06 | 200 | 163 | 7 | c6bbd33bca86ac7a76a7ba704b3e141237d04549 | |
| ToppCell | (5)_Fibroblasts|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 9.15e-06 | 200 | 163 | 7 | 22c839f27d3abdf86bfabdfa305f205dd899a9dc | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-intermediate_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 9.15e-06 | 200 | 163 | 7 | d769723f8fcb37d9b86589e0c41c1d7f16393cfe | |
| ToppCell | wk_08-11-Epithelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.15e-06 | 200 | 163 | 7 | 445fc7995ffc440c6256a6aab0bbf33fb0fea028 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.15e-06 | 200 | 163 | 7 | 0bfd41c12887479ceb62c3db0a3c3ba5007eb62b | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Mesothelial-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 9.15e-06 | 200 | 163 | 7 | 3be373e9a30e19334e4709e2819fb83cc777d104 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.15e-06 | 200 | 163 | 7 | d30316836494f33ca46d4e415fd2ed179e9cb5ee | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Nr2f2_Necab1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.28e-05 | 82 | 163 | 5 | 5d2fb64c01739258d5ab17d533ef41e2323605f2 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.85e-05 | 149 | 163 | 6 | 4b44108c40376a6b73258df40d2424e68f991383 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.39e-05 | 156 | 163 | 6 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.86e-05 | 161 | 163 | 6 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tregs|GI_large-bowel / Manually curated celltypes from each tissue | 2.96e-05 | 162 | 163 | 6 | 9a5e65c45f73a6a685b8362aa2e6aea77181caa3 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.96e-05 | 162 | 163 | 6 | 96c6e94a10b124a1d25dcd705ec5aaa8609c1089 | |
| ToppCell | 15-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 3.28e-05 | 165 | 163 | 6 | 531804467601e1ee1f771cffa21501f6d464ae10 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.39e-05 | 166 | 163 | 6 | a41a20cef053c67da2d435e3e132ce28f1661c03 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-05 | 167 | 163 | 6 | e1b1a952fce27ab9cf16919b290625ff4a75261e | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-regulatory_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.63e-05 | 168 | 163 | 6 | 2d2eab3190374f79f373e31c8b062ff4e1766396 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.63e-05 | 168 | 163 | 6 | df58156721457b34af1e81c0eb8a7243cbbfb303 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.75e-05 | 169 | 163 | 6 | 0ee74cc97a2db9cc16dc73424f74747afe13af90 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-05 | 169 | 163 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.87e-05 | 170 | 163 | 6 | bf589c4297ccc90e5f51e3d0fcc229548af4fcef | |
| ToppCell | normal-na-Lymphocytic_B-B_plasma-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.87e-05 | 170 | 163 | 6 | c5b87974dfddf9780051f7f5693eeeb0c606a3fe | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.00e-05 | 171 | 163 | 6 | 845f312f8cbe29d820da25f0e6d75deb382bbfd8 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-05 | 172 | 163 | 6 | 3f784aed340b50ddbec3f7dc0a5279180d38a2bb | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-classical_monocyte|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.13e-05 | 172 | 163 | 6 | a53c906539557594ef10368bc29aec4af063fd37 | |
| ToppCell | facs-BAT-Fat-3m-Myeloid-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-05 | 172 | 163 | 6 | 5f18c3f8eb8b7928901eede44c9b84b3c5efa1a9 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Airway_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.27e-05 | 173 | 163 | 6 | b23b408acc29a667cce104429afef1a6cf2720a5 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.27e-05 | 173 | 163 | 6 | 9acad7ec70f713fe3db6cef7bbe3b183bf16ae67 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.41e-05 | 174 | 163 | 6 | 0df738309b7b6e77675ea74e7a87e66601b0073d | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.41e-05 | 174 | 163 | 6 | a7ade7372e83edd4e3983e77f8417b51f0b47340 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-05 | 174 | 163 | 6 | 9c916af5eebd932f67dc9117e1d26ff194a2ff2c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-05 | 174 | 163 | 6 | bc71521f44a5fe013af42b06b5d1bd2446ecf3b5 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.70e-05 | 176 | 163 | 6 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.70e-05 | 176 | 163 | 6 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-05 | 176 | 163 | 6 | 5e46a09a36b9645b1b1fcb0b64bd0898561af3a9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.70e-05 | 176 | 163 | 6 | 4843af68f013732c28a8b8edad30d5fa0f2b084b | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.85e-05 | 177 | 163 | 6 | 7af1a19692f7fe8f691178a4e57d62bc379e3d56 | |
| Drug | Ethacrynic acid [58-54-8]; Up 200; 13.2uM; PC3; HT_HG-U133A | 1.48e-06 | 196 | 162 | 10 | 5742_UP | |
| Disease | platelet crit | HBS1L ABCC4 NHSL2 MYO9B MCFD2 ANP32B TRPC6 EPB41L5 LAMA5 ABCC5 SYF2 IGF1R P3H2 CNTN5 YLPM1 NMT1 FYB1 CDH3 PLCE1 | 1.09e-06 | 952 | 160 | 19 | EFO_0007985 |
| Disease | platelet component distribution width | PRUNE2 HBS1L AKT3 PACSIN1 MYO9B LAMA5 ABCC5 DCAF5 JMY IGF1R P3H2 CNTN5 PPP1R9B TTLL1 FYB1 | 1.67e-05 | 755 | 160 | 15 | EFO_0007984 |
| Disease | Huntington's disease (implicated_via_orthology) | 2.66e-05 | 32 | 160 | 4 | DOID:12858 (implicated_via_orthology) | |
| Disease | colorectal cancer | ABCC4 CALB1 TRPC6 LAMA5 HAO1 ADCY8 CNTN5 LRP1 OLFM1 DCLRE1A LRBA HERC2 CDH3 | 2.75e-05 | 604 | 160 | 13 | MONDO_0005575 |
| Disease | urate measurement, bone density | FRAS1 ZNF618 TRPC6 LAMA5 GBE1 QRICH1 GALNT9 CEP70 OLFM1 PRKAR2A TTLL1 PEAK1 CABIN1 | 3.53e-05 | 619 | 160 | 13 | EFO_0003923, EFO_0004531 |
| Disease | nephroblastoma (is_implicated_in) | 5.45e-05 | 14 | 160 | 3 | DOID:2154 (is_implicated_in) | |
| Disease | renal cell carcinoma (biomarker_via_orthology) | 5.45e-05 | 14 | 160 | 3 | DOID:4450 (biomarker_via_orthology) | |
| Disease | Schizophrenia | MYT1L SOX5 CALB1 MYO9B FOLH1 APBA2 ITIH3 NCS1 CRMP1 SEMA3D NTNG2 UHMK1 CNTNAP2 LRP1 PPP1R9B | 9.82e-05 | 883 | 160 | 15 | C0036341 |
| Disease | serum iron measurement | 1.08e-04 | 86 | 160 | 5 | EFO_0006332 | |
| Disease | dimethylglycine measurement | 1.14e-04 | 46 | 160 | 4 | EFO_0010476 | |
| Disease | eye color | 1.33e-04 | 90 | 160 | 5 | EFO_0003949 | |
| Disease | nephrotic syndrome type 2 (is_implicated_in) | 1.74e-04 | 4 | 160 | 2 | DOID:0080379 (is_implicated_in) | |
| Disease | glucose measurement | 2.42e-04 | 380 | 160 | 9 | EFO_0004468 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 2.63e-04 | 57 | 160 | 4 | DOID:10652 (implicated_via_orthology) | |
| Disease | axial length measurement, refractive error | 4.32e-04 | 6 | 160 | 2 | EFO_0005318, MONDO_0004892 | |
| Disease | dynactin subunit 2 measurement | 4.32e-04 | 6 | 160 | 2 | EFO_0020338 | |
| Disease | complement component 1 q subcomponent-binding protein, mitochondrial measurement | 4.32e-04 | 6 | 160 | 2 | EFO_0020280 | |
| Disease | hyperthyroidism (biomarker_via_orthology) | 4.64e-04 | 28 | 160 | 3 | DOID:7998 (biomarker_via_orthology) | |
| Disease | intelligence, response to cranial radiation therapy | 4.64e-04 | 28 | 160 | 3 | EFO_0004337, EFO_0010950 | |
| Disease | radiation-induced disorder | 4.89e-04 | 67 | 160 | 4 | EFO_0009565 | |
| Disease | beta-citrylglutamate measurement | 6.03e-04 | 7 | 160 | 2 | EFO_0800060 | |
| Disease | retinal detachment | 6.03e-04 | 7 | 160 | 2 | EFO_0005773 | |
| Disease | electrocardiography | SOX5 MYCBP2 PACSIN1 TAB2 NCS1 UBE2R2 IGF1R CNTNAP2 CACNA1G PLCE1 | 6.62e-04 | 530 | 160 | 10 | EFO_0004327 |
| Disease | Hyperkinesia | 6.91e-04 | 32 | 160 | 3 | C3887506 | |
| Disease | Hyperkinesia, Generalized | 6.91e-04 | 32 | 160 | 3 | C0751217 | |
| Disease | McCune Albright syndrome (implicated_via_orthology) | 8.01e-04 | 8 | 160 | 2 | DOID:1858 (implicated_via_orthology) | |
| Disease | risk-taking behaviour | MYT1L SOX5 AKT3 ZNF618 TRPC6 TMEM63C ITIH3 IGF1R DNAJC11 TTC29 CACNA1G GNAI2 | 9.81e-04 | 764 | 160 | 12 | EFO_0008579 |
| Disease | obsolete_red blood cell distribution width | HBS1L MYO9B ANP32B MYO19 SPTB ABCC5 ARFIP1 DENND4C IGF1R FIG4 CNTN5 SYNE2 YLPM1 NMT1 CDH3 G6PD PLS1 | 1.07e-03 | 1347 | 160 | 17 | EFO_0005192 |
| Disease | chronotype measurement | SOX5 MYCBP2 ZNF618 GBE1 CDH19 ADCY8 NTNG2 FIG4 CNTN5 TTC29 GNAI2 CFAP61 NMT1 | 1.08e-03 | 882 | 160 | 13 | EFO_0008328 |
| Disease | systemic scleroderma | 1.20e-03 | 85 | 160 | 4 | EFO_0000717 | |
| Disease | Autism Spectrum Disorders | 1.20e-03 | 85 | 160 | 4 | C1510586 | |
| Disease | Bipolar Disorder | 1.23e-03 | 477 | 160 | 9 | C0005586 | |
| Disease | macrovascular complications of diabetes | 1.28e-03 | 10 | 160 | 2 | EFO_0010977 | |
| Disease | carboxypeptidase B2 measurement | 1.28e-03 | 10 | 160 | 2 | EFO_0008069 | |
| Disease | adseverin measurement | 1.28e-03 | 10 | 160 | 2 | EFO_0801358 | |
| Disease | osteonecrosis (is_implicated_in) | 1.28e-03 | 10 | 160 | 2 | DOID:10159 (is_implicated_in) | |
| Disease | f-box/LRR-repeat protein 4 measurement | 1.28e-03 | 10 | 160 | 2 | EFO_0802538 | |
| Disease | colorectal cancer, colorectal adenoma | 1.47e-03 | 152 | 160 | 5 | EFO_0005406, MONDO_0005575 | |
| Disease | prostatic hypertrophy (is_marker_for) | 1.56e-03 | 11 | 160 | 2 | DOID:11132 (is_marker_for) | |
| Disease | Colorectal Carcinoma | ABCC4 FOLH1 RBM10 ABCC5 F5 ADCY8 KL TOMM40L ANP32A LRP1 SESN2 | 1.62e-03 | 702 | 160 | 11 | C0009402 |
| Disease | spleen volume | 1.65e-03 | 43 | 160 | 3 | EFO_0600047 | |
| Disease | candidiasis (implicated_via_orthology) | 1.76e-03 | 44 | 160 | 3 | DOID:1508 (implicated_via_orthology) | |
| Disease | Pathological accumulation of air in tissues | 1.86e-03 | 12 | 160 | 2 | C0013990 | |
| Disease | nicotine dependence (implicated_via_orthology) | 1.86e-03 | 12 | 160 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | quality of life during menstruation measurement, decreased attention | 1.86e-03 | 12 | 160 | 2 | EFO_0009366, NCIT_C117245 | |
| Disease | hair colour measurement | 2.01e-03 | 615 | 160 | 10 | EFO_0007822 | |
| Disease | hemolysis | 2.13e-03 | 47 | 160 | 3 | EFO_0009473 | |
| Disease | Anemia, Hemolytic, Acquired | 2.19e-03 | 13 | 160 | 2 | C0002879 | |
| Disease | Anemia, Hemolytic | 2.19e-03 | 13 | 160 | 2 | C0002878 | |
| Disease | Anemia, Microangiopathic | 2.19e-03 | 13 | 160 | 2 | C0002889 | |
| Disease | Microangiopathic hemolytic anemia | 2.19e-03 | 13 | 160 | 2 | C0221021 | |
| Disease | T-cell surface glycoprotein CD3 epsilon chain measurement | 2.19e-03 | 13 | 160 | 2 | EFO_0802114 | |
| Disease | cup-to-disc ratio measurement | 2.49e-03 | 430 | 160 | 8 | EFO_0006939 | |
| Disease | FEV/FEC ratio | SOX5 DCHS2 FRAS1 EPB41L5 BCHE ARFIP1 ADCY8 GID4 CNTN5 SYNE2 YLPM1 CNTNAP2 LRP1 MTCL1 CTTN | 2.87e-03 | 1228 | 160 | 15 | EFO_0004713 |
| Disease | cortical thickness | SOX5 AKT3 MYCBP2 FAT3 CRK CRMP1 PPP2R2A IGF1R YLPM1 LRP1 PRKAR2A GNAI2 MTCL1 PLCE1 | 3.05e-03 | 1113 | 160 | 14 | EFO_0004840 |
| Disease | Antihypertensive use measurement | 3.33e-03 | 265 | 160 | 6 | EFO_0009927 | |
| Disease | cervical artery dissection | 3.77e-03 | 17 | 160 | 2 | EFO_1000059 | |
| Disease | Ischemic stroke, venous thromboembolism, stroke, Abnormal thrombosis, deep vein thrombosis, pulmonary embolism | 3.77e-03 | 17 | 160 | 2 | EFO_0000712, EFO_0003827, EFO_0003907, EFO_0004286, HP_0001977, HP_0002140 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 3.83e-03 | 364 | 160 | 7 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | HbA1c measurement | 3.90e-03 | 675 | 160 | 10 | EFO_0004541 | |
| Disease | neuroticism measurement | MYT1L SOX5 PACSIN3 GBE1 QRICH1 CDH19 DCAF5 AATK DCAF8L1 CNTN5 YLPM1 GNAI2 | 4.10e-03 | 909 | 160 | 12 | EFO_0007660 |
| Disease | blood nickel measurement | 4.20e-03 | 120 | 160 | 4 | EFO_0007583 | |
| Disease | smoking status measurement | MYT1L AKT3 CALB1 FAT3 TMEM63C GBE1 PLEKHB1 DCAF5 ADCY8 IGF1R CNTN5 TTC29 CNTNAP2 OLFM1 | 4.39e-03 | 1160 | 160 | 14 | EFO_0006527 |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | SOX5 AKT3 CALB1 PACSIN3 GBE1 PLEKHB1 IGF1R AATK DNAJC11 TTC29 OLFM1 | 4.43e-03 | 801 | 160 | 11 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | cutaneous melanoma, hair color | 4.68e-03 | 62 | 160 | 3 | EFO_0000389, EFO_0003924 | |
| Disease | reticulocyte measurement | TSPAN15 HBS1L MYO9B ANP32B SPTB ARFIP1 ADCY8 CRK MAP3K5 UBE2R2 CNTN5 SYNE2 PLS1 | 4.98e-03 | 1053 | 160 | 13 | EFO_0010700 |
| Disease | prostate adenocarcinoma (is_implicated_in) | 5.21e-03 | 20 | 160 | 2 | DOID:2526 (is_implicated_in) | |
| Disease | body fat percentage | 5.31e-03 | 488 | 160 | 8 | EFO_0007800 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KDRDNEELYSQSYDA | 966 | P40145 | |
| QENVDDYYDTGEELG | 6 | P53355 | |
| ENYREALGDVVGDYN | 411 | P06276 | |
| YGEYFLAELIEAQDE | 211 | Q8NHU2 | |
| NSDYETYLSADDLRI | 186 | P63151 | |
| EYDAYRTDLEELNLG | 266 | P53367 | |
| DDFYDGIKRLYNEDN | 331 | Q14094 | |
| YVNNTSEEEDYDEGL | 76 | Q99767 | |
| ELYRNYGILADATEQ | 6 | Q9BZZ5 | |
| IDYELIDQDARDLYD | 186 | P07355 | |
| QLTYLDGYDRDDKEA | 141 | P39687 | |
| QLTYLDGYDREDQEA | 141 | Q92688 | |
| EYEDENLYEGLNLDD | 181 | P11912 | |
| IDYELIDQDAQDLYD | 186 | A6NMY6 | |
| YRQDESYNFEGDIAL | 546 | P00736 | |
| EYLAPEVLEDNDYGR | 311 | Q9Y243 | |
| LRNGTEIDLESDYRY | 136 | O94779 | |
| YVRALFDFNGNDEED | 136 | P46108 | |
| DRVENDGENYVQDAY | 221 | O75901 | |
| DYRDQDYRTEQGEEE | 101 | P98175 | |
| GLERIYNISDANYRE | 156 | Q6ZP01 | |
| ENGRVDDIFSDLYYV | 561 | Q2TAL8 | |
| EESELDLTYGNRYKN | 416 | P11413 | |
| DSYLEEDVYQLQELR | 366 | Q9Y4B5 | |
| NVRGYNYDEDFEDDD | 6 | Q9Y450 | |
| YINVGDLAREEQLYD | 31 | Q9Y3D8 | |
| DLAREEQLYDGYDEE | 36 | Q9Y3D8 | |
| EDNRFIYDGIDSNFE | 606 | P0C881 | |
| EDNRFIYDGIDSNFE | 606 | B2RC85 | |
| ELYLQNNYLTDEGLD | 266 | Q7Z5L7 | |
| SEEELDNEDYYSLLN | 6 | Q9NVH1 | |
| DNEDYYSLLNVRREA | 11 | Q9NVH1 | |
| ESEYLIGQALYANRE | 461 | Q5JU00 | |
| NLDYEDSSFYELGVE | 306 | Q9Y5G7 | |
| DYVEYAGQVQFDERE | 2606 | Q86XX4 | |
| FYEQYDDDEIGALDN | 266 | Q96GA3 | |
| DLDELNVYARGTDYD | 101 | Q8IYB1 | |
| ARLDQLEADYYDLQL | 521 | Q8N9B5 | |
| ELYTLLNENYVEDDD | 171 | P30419 | |
| KLYDLDNDGYITRNE | 106 | P62166 | |
| RDDDKNNDGYIDYAE | 126 | Q8NI22 | |
| YLRAQQEEYAVEGLE | 446 | Q96H55 | |
| DFLSNDDYAVYVREN | 2556 | O95714 | |
| EYGYNAQLSDRISLD | 116 | Q9HCQ5 | |
| NSLQNFDYGVLEDLY | 326 | Q8N6Y2 | |
| EYQVLYIADDNEIRS | 3866 | Q07954 | |
| EGDLVYVNYARTEDF | 171 | Q04609 | |
| NYEESRGNYLVDVDG | 76 | P80404 | |
| YYSELEEQLTDEFNA | 316 | Q9P1W3 | |
| EEQLEGNYSFYVLDN | 411 | P08069 | |
| ETYDATLEDLDNLYN | 31 | Q99645 | |
| DNSGYVSDYELQDLF | 26 | Q14651 | |
| DLSNYEELTDYGDQL | 61 | Q9UBM4 | |
| DDNENVDLDKRLQYY | 151 | Q8IXQ8 | |
| DSYDEILNGYEENSV | 311 | Q9H792 | |
| VLNELQEEIGAYDYD | 191 | Q99784 | |
| QEEIGAYDYDELQSR | 196 | Q99784 | |
| AYDYDELQSRVSNLE | 201 | Q99784 | |
| SYLADNDGEIYDDIA | 761 | O15117 | |
| YYRSGANDEETLADN | 26 | Q9UJM8 | |
| RDQYILSGSDDFNLY | 291 | Q96JK2 | |
| LENYYRLADDLSNAA | 296 | Q9HD23 | |
| AQLDYRQYLSDEIDL | 481 | P50851 | |
| DSRIIYDYGTDNFEE | 26 | P20774 | |
| ETRYSVLNNDDYFAD | 26 | Q1ED39 | |
| VEQDNDLELADAYYL | 3051 | O15230 | |
| DVLDNVDYYESLLDD | 341 | Q8IVL5 | |
| DDDGSFLNSRIQYYI | 1536 | Q6V1P9 | |
| RALYDYDGQEQDELS | 391 | Q9BY11 | |
| NSDDFDYEELKNGDY | 216 | Q8IVV7 | |
| ARAVYQDADIYLLDD | 546 | O15439 | |
| DEDTYYLQVRGRENF | 351 | O15350 | |
| DNILFGKEYDEERYN | 641 | O15440 | |
| RNGELLDRESQAVYY | 541 | Q9BYE9 | |
| QLAAYNLQAELGDYD | 161 | Q9HCM4 | |
| DYSEYFGLQVDEDAL | 376 | Q04446 | |
| DNAAYYLNDLERIAA | 151 | P19086 | |
| GRDYHNDLNAVERYD | 406 | Q53GT1 | |
| DGQRYEELDDSLYLG | 196 | Q9BX69 | |
| QSLEEIQRLYEAGDY | 691 | Q9Y6J0 | |
| DYIYNLDESEGVCDL | 391 | Q16254 | |
| YLEGYFSEEQLRALN | 2916 | P51587 | |
| LSVDLERYYQTENED | 251 | O43497 | |
| EEENDYRNLDASPTY | 241 | Q8NHQ1 | |
| LYNELNLGRREEYDV | 71 | P20963 | |
| EELYEDHGDTLSLQY | 531 | Q92562 | |
| SYIDRDSEYLLQENE | 161 | Q9H2U1 | |
| SGRLNYDEKNRYDLE | 216 | Q8TDW7 | |
| LVVYIRYQDQDDDDE | 336 | Q3MIR4 | |
| ELYDQDGNGYIDENE | 196 | P05937 | |
| YSFLGNRVDEDNEED | 291 | Q5JW98 | |
| NIDIEAFDNEYGIAY | 1861 | Q5VZ89 | |
| SYDRGEEEAYLNFIA | 631 | Q96BJ8 | |
| YEAELLGRYPEEDNE | 211 | O75064 | |
| LERQIYAFEGSYLED | 36 | Q9HAF1 | |
| DDGLHAEDDQLRVYY | 876 | Q9UEF7 | |
| DDGDNFYVIERGTYD | 171 | P13861 | |
| LIQQSLDDYDAGRYS | 546 | Q8WUQ7 | |
| DGTELLASYNDEDIY | 401 | A6NGE4 | |
| TNGEFDYLDLDYEIT | 301 | Q9UHC6 | |
| YDEGLYRFNSLNDLS | 371 | Q6PJP8 | |
| ESDQLNIYIREYSAD | 351 | Q16820 | |
| EDDTRDNVFYYGEEG | 691 | P22223 | |
| SDQDESYDYLNELGP | 741 | Q9H159 | |
| NSLRADYDNLVLDYE | 501 | Q02224 | |
| DYDNLVLDYEQLRTE | 506 | Q02224 | |
| NDDQSLYADVYLEDG | 26 | Q14194 | |
| LYDYAGQEADELSFR | 371 | Q9UKS6 | |
| LEYDYEYDENGDRVV | 671 | Q99683 | |
| GYYRNGSAELDDENV | 391 | Q96CW9 | |
| DDYDYGEVNQLLERN | 406 | P58004 | |
| PYNDDADIDYINERN | 201 | O95926 | |
| LEYEEGSYNLDSRDV | 1401 | Q8WUY3 | |
| NIYDYLDSSEPAENE | 1736 | Q8WUY3 | |
| NEKTEDYYENLGRAL | 1631 | Q8WXH0 | |
| TRYLYGEGDLNFSDD | 51 | Q9NYJ8 | |
| DLTGEVEENERYAYE | 1116 | Q9UMZ2 | |
| EDEESDADYDYQNRL | 716 | P12259 | |
| DADYDYQNRLAAALG | 721 | P12259 | |
| QPRALDSGYDTENYE | 931 | Q6ZMQ8 | |
| EEYEEQYSEARLVGQ | 146 | Q5HYW2 | |
| YDYESLSDDNILEDR | 1591 | Q9P212 | |
| LLIGNRDSLDNSYYD | 401 | Q8IVG5 | |
| YEDSDADLQLQGFYE | 451 | Q06033 | |
| DSAAYYLNDLERIAQ | 151 | P04899 | |
| LRDINQGEELFSNYY | 281 | Q8NE22 | |
| EIYESENGEPRGDNY | 276 | P21815 | |
| ENGEPRGDNYRAYED | 281 | P21815 | |
| LYYRSEFDGDLQSQL | 1881 | O75592 | |
| LLYDEESENAYDIRL | 31 | Q9NY99 | |
| EARVQEYGELDAKDY | 461 | Q9NVU7 | |
| VYRDLVRNSQDDYDE | 131 | O76094 | |
| DRQGATYLFDLDYVE | 291 | O43463 | |
| DGADTYFDELQDIYL | 316 | O95025 | |
| DYQGLRASIDAYDNF | 1476 | P53675 | |
| EEQFEQYLRDESGLN | 116 | Q8WYJ6 | |
| LYRGNADEELFQDQD | 86 | Q96A61 | |
| EDKAGNYEEALQLYQ | 21 | O75351 | |
| SYGSDAEEEEYRQQL | 1156 | Q9UDY2 | |
| LVGAYPNYNEEEEER | 36 | Q9H1C4 | |
| VRGYRYLEEDNSDES | 536 | Q9H1C4 | |
| DDRLGKNEVYDYLQE | 866 | Q5T7W0 | |
| QLLNYEDESDVSLYG | 76 | Q0ZLH3 | |
| AEDSTYDEYENDLGI | 481 | Q14247 | |
| ALYEYLRQSVGNEAE | 116 | P05452 | |
| RNDSIYAGASQYDLD | 216 | Q7Z5S9 | |
| LGYYHDETAQDEEDR | 51 | Q9UF11 | |
| LDIDFGAEGNRYYEA | 66 | Q9UKY0 | |
| DNIRRGIENYYDDLD | 126 | O95858 | |
| RDANEAQQYYLDADE | 1581 | P11277 | |
| EDAVYLDSEPQRQEY | 146 | O43548 | |
| HDTDGNLIIDEYYDN | 306 | O43548 | |
| SEADIDEGLYSRQLY | 46 | P22314 | |
| TERIYDDDFFQNLDG | 556 | P22314 | |
| ERDYQDDTLELYNRE | 1231 | P49750 | |
| VLDNGILSYYDSQDD | 21 | Q9HB20 | |
| EEAGRLLLENYEEYA | 131 | Q16763 | |
| LYEEDGQLLEAAEHY | 191 | Q8NA56 | |
| QFDGEYRGDDYTATL | 136 | Q969M1 | |
| IQAEDINGEIYDEYD | 726 | P35711 | |
| NSSDLLYDDLYDDDI | 201 | Q712K3 | |
| LQQDDFYAYDEDGTR | 201 | Q9Y210 | |
| DYNRFQELIQEYEDS | 671 | Q9NV66 | |
| LNVLDDDYLENEEEY | 326 | Q8TAS1 | |
| GNYEILYDEELAQGD | 376 | O95922 | |
| TNRDDSDNGDINYDY | 146 | Q5T200 | |
| PLEQELRDDDFYAYD | 141 | Q9HCX4 | |
| EGDLVYVNYARTEDF | 161 | Q9Y3Q0 | |
| PRVSYQYRQDADEEA | 401 | Q9NR99 | |
| QEDGYYFLLQERNAD | 101 | Q13459 | |
| LSGQAYDEAYAEFQR | 1546 | P52179 | |
| DIDYYLGQSFREQLA | 1521 | Q5VU43 | |
| NDEYDNYDELVAKSL | 191 | Q9UL68 | |
| QRYAQYGEDDEETGE | 611 | Q96SB3 |